版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領(lǐng)
文檔簡介
1、新疆醫(yī)科大學碩士學位論文中藥復(fù)方治療癌性疼痛的系統(tǒng)評價及用藥規(guī)律分析姓名:王慶全申請學位級別:碩士專業(yè):中西醫(yī)結(jié)合臨床指導教師:杜業(yè)勤2010-04新疆醫(yī)科大學醫(yī)學碩士學位論文 新疆醫(yī)科大學醫(yī)學碩士學位論文 —2—Systematic review and medication principles on compound Chinese medicine for cancer pain Postgraduate: Wang Qing
2、-quan Supervisor: Du Ye-qin Abstract Objective: To evaluate the methodological quality of the randomized controlled trials (RCT) literatures on cancer pain with Traditional Chinese medicine (TCM), the effectiveness and
3、safety of the treatment for cancer pain with TCM, and analysis the law of Chinese herbals used in the included studies, with the theory and method of Evidence-based medicine (EBM) in recent years. Methods: The Cochrane l
4、ibrary, MEDLINE, CBM, CNKI, VIP, WanFang were searched electronically. Relevant journals, academic conference proceedings and the references lists of identified documents were also searched by hand. Randomized or quasi-r
5、andomized controlled clinical trials of TCM therapies for cancer pain were selected for this study. The quality of included studies was assessed according to the criteria recommended by the Cochrane Handbook for systemat
6、ic Reviews of interventions and meta-analyses were performed for homogeneous studies using The Cochrane collaboration’s Review manager 4.2.2 software. Chinese herbals used in the included studies given concrete prescript
7、ion were statistically analyzed. Results: 145 papers of clinical RCTs on Chinese medical herbals in the treatment of cancer pain were published on 81 kinds of journals. The quality of 3 studies, 2 studies and another 140
8、 studies was graded A, B, C(low) respectively. Meta -analyses showed that TCM is superior to xiaoyantong and amount to qumaduo in total effective rate, early potency and prolonged action. In 145 literatures, 92 compound
9、prescriptions were analyzed. Among them, 40 prescriptions were internal use including 101 drugs, 210 frequencies; and 52 prescriptions were external use including 110 drugs, 439 frequencies. Conclusion: 1. At present, th
10、e quantity of RCT on Traditional Chinese Medicine (TCM) therapies for cancer pain has raised sharply year by year, and the quality of the studies has enhanced increasingly, however, its methodological quality was Poor in
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 眾賞文庫僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
- 6. 下載文件中如有侵權(quán)或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 中藥復(fù)方治療兒童支原體肺炎的系統(tǒng)評價及用藥規(guī)律研究.pdf
- 中藥復(fù)方止痛膠囊治療癌性疼痛的臨床及實驗研究.pdf
- 中藥復(fù)方治療糖尿病腎病用藥規(guī)律的研究.pdf
- 治療肺纖維化中藥復(fù)方用藥規(guī)律的數(shù)據(jù)挖掘
- 基于期刊文獻探討癌性疼痛組方用藥規(guī)律.pdf
- 中醫(yī)藥治療乳腺增生病的文獻系統(tǒng)評價及中藥用藥規(guī)律分析.pdf
- 復(fù)方頑痛寧酊治療癌性疼痛的實驗及臨床研究.pdf
- 針刺治療癌性疼痛的系統(tǒng)評價及臨床預(yù)初試驗.pdf
- 治療骨壞死中藥處方用藥規(guī)律研究分析.pdf
- 中藥復(fù)方治療兒童多動癥(ADHD)的系統(tǒng)評價、證治規(guī)律及作用機制研究.pdf
- 中藥復(fù)方保留灌腸治療慢性腎衰的系統(tǒng)評價.pdf
- 癌性疼痛及其治療
- 癌性疼痛的評估與治療
- 112章.癌性疼痛治療
- 中藥復(fù)方治療潰瘍性結(jié)腸炎的證治規(guī)律研究.pdf
- 溫陽利水法中藥復(fù)方治療肺心病心衰的系統(tǒng)評價.pdf
- 癌痛治療時機及合理用藥分析解析
- 宮頸癌中晚期的治療,復(fù)方菝葜是用藥選擇
- 用佐劑性關(guān)節(jié)炎大鼠探討中藥治療PA的復(fù)方配伍規(guī)律.pdf
- 中藥復(fù)方治療子宮內(nèi)膜異位癥的系統(tǒng)評價.pdf
評論
0/150
提交評論